AGITG Innovation Fund – Open for Applications

The AGITG Innovation Fund is made possible through generous contributions from the Spencer Gibson Foundation, the His Honour Alan Bishop Fund and with donations raised through the GI Cancer Institute’s Gutsy Challenge. AGITG members can apply for up to $200,000 to support a new AGITG pilot trial. “The AGITG Innovation … Read More

April 18, 2017

Merck partners with the AGITG

The AGITG in partnership with Merck are pleased to announce two exciting opportunities for AGITG members. “With generous untied financial support from Merck, two significant opportunities are available for our membership through the AGITG Clinical Research Fellowship in GI Cancer and the Kristian Anderson Award.  These opportunities, provided by Merck, … Read More

April 12, 2017

Health Economics in cancer research

CREST, the Cancer Research Economics Support Team is holding a workshop at the Centre for Health Economics Research and Evaluation, UTS Title:  Understanding health economics in cancer research Date:  9:30 am – 4:30 pm Monday 22nd May, 2017 Location: Room D.2.20, Block D, Building 5, 1 Quay St, Ultimo, NSW … Read More

April 12, 2017

CHALLENGE clinical trial

CHALLENGE: Colon Health And Life Long Exercise change A phase III study of the impact of a physical activity program on disease-free survival in patients with high risk stage II or stage III colon cancer A clinical trial endorsed by the AGITG The CHALLENGE trial is now running in 7 … Read More

April 12, 2017

CAP makes submission to Senate Inquiry

On 29 November 2016 the Senate established a select committee known as the Select Committee into Funding for Research into Cancers with Low Survival Rates to inquire and report on the impact of health research funding models on the availability of funding for research into cancers with low survival rates. … Read More

April 12, 2017

AGITG’s new Research Fellow: Dr Monica Tang

The AGITG has two new Research Fellows for 2017. This month we spoke with Dr Monica Tang and asked her about what she hopes to achieve during her Fellowship year. AGITG: Why did you decide to focus on GI cancer? Dr Tang: I find GI cancers interesting because they encompass … Read More

April 11, 2017

John Zalcberg Award is open for applications

The John Zalcberg OAM Award for Excellence in AGITG Research The John Zalcberg OAM Award for Excellence in AGITG Research recognises a member of the Australasian Gastro-Intestinal Trials Group (AGITG) who has made a significant and outstanding leadership contribution to AGITG research over a sustained period. Nominations may recognise the … Read More

April 11, 2017

AGITG Trial News

The AGITG currently has eight  studies open to recruitment and ten  studies in follow up. The  table below details  the trials that  are currently  accruing patients. Recruited Target ACTICCA-1- Gallbladder carcinoma 2 50 ALT-GIST- GI Stromal Tumour 48 60 ASCOLT — Colorectal cancer 202 300 CONTROL NETs — NeuroEndocrine Tumour … Read More

April 11, 2017

Interview with new Fellow

The AGITG has two new Research Fellows. This month we talked to Dr Namrata Nayar about her interest in GI cancer and what she hopes to achieve during her Fellowship over the next year. AGITG: Why did you decide to focus on GI cancer? Dr Nayar:   During my Oncology … Read More

March 13, 2017

Opportunities to attend the ASM

Special Offer Registration Rate Data Managers, Fellows and Registrars are eligible for a Special Offer Registration Rate of AUD$50 (normally $420). Conditions: Offer valid for the first 40 registrations for the Data Manager/Fellow/Registrar category only. You must attend the entire meeting to be eligible. Once the special offer rate is … Read More

March 13, 2017